{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:35:36Z","timestamp":1787060136376,"version":"build-2736575974"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["2021RIS-001"],"award-info":[{"award-number":["2021RIS-001"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["2019R1C1C1004387"],"award-info":[{"award-number":["2019R1C1C1004387"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013128","name":"Korea Technology and Information Promotion Agency for SMEs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013128","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013129","name":"Ministry of SMEs and Startups","doi-asserted-by":"publisher","award":["S3174595"],"award-info":[{"award-number":["S3174595"]}],"id":[{"id":"10.13039\/501100013129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002614","name":"Korea National University of Transportation","doi-asserted-by":"publisher","award":["2022R1F1A1074895"],"award-info":[{"award-number":["2022R1F1A1074895"]}],"id":[{"id":"10.13039\/501100002614","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.bcp.2023.115415","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T19:13:06Z","timestamp":1673896386000},"page":"115415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Orobol, 3\u2032-hydroxy-genistein, suppresses the development and regrowth of cutaneous SCC"],"prefix":"10.1016","volume":"209","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4385-2046","authenticated-orcid":false,"given":"Eunmiri","family":"Roh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Eun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianshun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Ho","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung-Gee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinli","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zigang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bcp.2023.115415_b0005","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2340\/00015555-3110","article-title":"Characteristics and Trends of Cutaneous Squamous Cell Carcinoma in a Patient Cohort in Finland 2006\u20132015","volume":"99","author":"Korhonen","year":"2019","journal-title":"Acta Derm. Venereol."},{"issue":"3","key":"10.1016\/j.bcp.2023.115415_b0010","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.soncn.2016.05.005","article-title":"Ultraviolet Radiation Exposure and Its Impact on Skin Cancer Risk","volume":"32","author":"Watson","year":"2016","journal-title":"Semin. Oncol. Nurs."},{"issue":"4","key":"10.1016\/j.bcp.2023.115415_b0015","first-page":"759","article-title":"Mortality risk from squamous cell skin cancer, Journal of clinical oncology : official journal of the American Society of","volume":"23","author":"Clayman","year":"2005","journal-title":"Clin. Oncol."},{"issue":"Suppl 2","key":"10.1016\/j.bcp.2023.115415_b0020","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1017\/S0022215113000303","article-title":"Quality of life assessment in patients treated for metastatic cutaneous squamous cell carcinoma of the head and neck","volume":"127","author":"Wang","year":"2013","journal-title":"J. Laryngol. Otol."},{"issue":"8","key":"10.1016\/j.bcp.2023.115415_b0025","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.bjps.2018.03.019","article-title":"A 5-year follow-up study of 633 cutaneous SCC excisions: Rates of local recurrence and lymph node metastasis","volume":"71","author":"Khan","year":"2018","journal-title":"J. Plast. Reconstr. Aesthet. Surg."},{"issue":"2","key":"10.1016\/j.bcp.2023.115415_b0030","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.amepre.2014.08.036","article-title":"Prevalence and costs of skin cancer treatment in the U.S., 2002\u20132006 and 2007\u20132011","volume":"48","author":"Guy","year":"2015","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.bcp.2023.115415_b0035","doi-asserted-by":"crossref","unstructured":"H.W. Rogers, M.A. Weinstock, S.R. Feldman, B.M. Coldiron, Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012, JAMA dermatology 151(10) (2015) 1081-6.","DOI":"10.1001\/jamadermatol.2015.1187"},{"issue":"6","key":"10.1016\/j.bcp.2023.115415_b0040","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jaad.2012.11.037","article-title":"Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012","volume":"68","author":"Karia","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"issue":"4","key":"10.1016\/j.bcp.2023.115415_b0045","doi-asserted-by":"crossref","first-page":"408","DOI":"10.5114\/ada.2018.75841","article-title":"Outdoor work as a risk factor for high-grade cutaneous squamous cell carcinoma of the head and neck","volume":"35","author":"Szewczyk","year":"2018","journal-title":"Postepy dermatologii i alergologii"},{"key":"10.1016\/j.bcp.2023.115415_b0050","doi-asserted-by":"crossref","unstructured":"H.M. Gloster, Jr., K. Neal, Skin cancer in skin of color, Journal of the American Academy of Dermatology 55(5) (2006) 741-60; quiz 761-4.","DOI":"10.1016\/j.jaad.2005.08.063"},{"issue":"4","key":"10.1016\/j.bcp.2023.115415_b0055","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.jaad.2013.11.038","article-title":"Skin cancer and photoprotection in people of color: a review and recommendations for physicians and the public","volume":"70","author":"Agbai","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"issue":"13","key":"10.1016\/j.bcp.2023.115415_b0060","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJM200103293441306","article-title":"Cutaneous squamous-cell carcinoma","volume":"344","author":"Alam","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.bcp.2023.115415_b0065","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/CAD.0b013e32809ef9e0","article-title":"Cutaneous squamous cell carcinoma responding serially to single-agent cetuximab","volume":"18","author":"Suen","year":"2007","journal-title":"Anticancer Drugs"},{"issue":"7","key":"10.1016\/j.bcp.2023.115415_b0070","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1001\/archderm.143.7.889","article-title":"Treatment of recurrent squamous cell carcinoma of the skin with cetuximab","volume":"143","author":"Bauman","year":"2007","journal-title":"Arch. Dermatol."},{"issue":"11","key":"10.1016\/j.bcp.2023.115415_b0075","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1200\/JCO.2008.17.0530","article-title":"Phase III study of gefitinib compared with intravenous methotrexate for recurrent squamous cell carcinoma of the head and neck [corrected]","volume":"27","author":"Stewart","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.bcp.2023.115415_b0080","first-page":"1066","article-title":"Combination of an EGFR blocker and a COX-2 inhibitor for the treatment of advanced cutaneous squamous cell carcinoma, Journal der Deutschen Dermatologischen Gesellschaft =","volume":"6","author":"Jalili","year":"2008","journal-title":"Journal of the German Society of Dermatology : JDDG"},{"issue":"1","key":"10.1016\/j.bcp.2023.115415_b0085","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1365-2133.2005.06709.x","article-title":"Treatment with gefitinib (ZD 1839) in a patient with advanced cutaneous squamous cell carcinoma","volume":"153","author":"Baltaci","year":"2005","journal-title":"Br. J. Dermatol."},{"issue":"10","key":"10.1016\/j.bcp.2023.115415_b0090","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1200\/JCO.2003.10.051","article-title":"Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck","volume":"21","author":"Cohen","year":"2003","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.bcp.2023.115415_b0095","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1805131","article-title":"PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma","volume":"379","author":"Migden","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2023.115415_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2022.05.051","article-title":"A comparison of invasive squamous cell carcinoma greater than 1 year after treatment with 5-fluorouracil, imiquimod, or photodynamic therapy with aminolevulinic acid","author":"Cheng","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"issue":"42","key":"10.1016\/j.bcp.2023.115415_b0105","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.1038\/s41388-018-0350-9","article-title":"Targeting PRPK and TOPK for skin cancer prevention and therapy","volume":"37","author":"Roh","year":"2018","journal-title":"Oncogene"},{"issue":"16","key":"10.1016\/j.bcp.2023.115415_b0110","article-title":"Suppression of the solar ultraviolet-induced skin carcinogenesis by TOPK inhibitor HI-TOPK-032","volume":"80","author":"Roh","year":"2020","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.bcp.2023.115415_b0115","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1440-0960.2002.00613.x","article-title":"Acitretin for chemoprevention of non-melanoma skin cancers in renal transplant recipients","volume":"43","author":"George","year":"2002","journal-title":"Australas J Dermatol"},{"issue":"4","key":"10.1016\/j.bcp.2023.115415_b0120","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1001\/archderm.141.4.456","article-title":"Low-dose retinoids in the prevention of cutaneous squamous cell carcinomas in organ transplant recipients: a 16-year retrospective study","volume":"141","author":"Harwood","year":"2005","journal-title":"Arch. Dermatol."},{"issue":"6","key":"10.1016\/j.bcp.2023.115415_b0125","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/BF02529741","article-title":"Formation of polyhydroxylated isoflavones from the soybean seed isoflavones daidzein and glycitein by bacteria isolated from tempe","volume":"164","author":"Klus","year":"1995","journal-title":"Arch. Microbiol."},{"issue":"8","key":"10.1016\/j.bcp.2023.115415_b0130","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.freeradbiomed.2006.06.026","article-title":"The intracellular genistein metabolite 5,7,3',4'-tetrahydroxyisoflavone mediates G2-M cell cycle arrest in cancer cells via modulation of the p38 signaling pathway","volume":"41","author":"Nguyen","year":"2006","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.bcp.2023.115415_b0135","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/bit.26795","article-title":"Circular permutation of a bacterial tyrosinase enables efficient polyphenol-specific oxidation and quantitative preparation of orobol","volume":"116","author":"Lee","year":"2019","journal-title":"Biotechnol. Bioeng."},{"issue":"1","key":"10.1016\/j.bcp.2023.115415_b0140","doi-asserted-by":"crossref","first-page":"8942","DOI":"10.1038\/s41598-019-43950-9","article-title":"Orobol, an Enzyme-Convertible Product of Genistein, exerts Anti-Obesity Effects by Targeting Casein Kinase 1 Epsilon","volume":"9","author":"Yang","year":"2019","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.bcp.2023.115415_b0145","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1021\/acschemneuro.9b00232","article-title":"Orobol: An Isoflavone Exhibiting Regulatory Multifunctionality against Four Pathological Features of Alzheimer's Disease","volume":"10","author":"Nam","year":"2019","journal-title":"ACS Chem. Nerosci."},{"issue":"1","key":"10.1016\/j.bcp.2023.115415_b0150","first-page":"195","article-title":"Differential regulation of the cytotoxicity activity of paclitaxel by orobol and platelet derived growth factor in human ovarian carcinoma cells","volume":"18","author":"Isonishi","year":"2007","journal-title":"Oncol. Rep."},{"issue":"2","key":"10.1016\/j.bcp.2023.115415_b0155","first-page":"337","article-title":"Differential sensitization by orobol in proliferating and quiescent human ovarian carcinoma cells","volume":"18","author":"Shiotsuka","year":"2001","journal-title":"Int. J. Oncol."},{"issue":"4","key":"10.1016\/j.bcp.2023.115415_b0160","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1142\/S0192415X18500441","article-title":"Inhibitory Effects of Amentoflavone and Orobol on Daclatasvir-Induced Resistance-Associated Variants of Hepatitis C Virus","volume":"46","author":"Lee","year":"2018","journal-title":"Am. J. Chin. Med."},{"issue":"1","key":"10.1016\/j.bcp.2023.115415_b0165","first-page":"1","article-title":"Inhibitory effects of orobol 7-O-D-glucoside from banaba (Lagerstroemia speciosa L.) on human rhinoviruses replication","volume":"51","author":"Choi","year":"2010","journal-title":"Lett. Appl. Microbiol."},{"issue":"11","key":"10.1016\/j.bcp.2023.115415_b0170","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/nbt.2017","article-title":"Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity","volume":"29","author":"Anastassiadis","year":"2011","journal-title":"Nat. Biotechnol."},{"issue":"31","key":"10.1016\/j.bcp.2023.115415_b0175","doi-asserted-by":"crossref","first-page":"4091","DOI":"10.1038\/onc.2015.471","article-title":"Fyn is a redox sensor involved in solar ultraviolet light-induced signal transduction in skin carcinogenesis","volume":"35","author":"Kim","year":"2016","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.bcp.2023.115415_b0180","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10585-007-9130-6","article-title":"The tumor cell-host organ interface in the early onset of metastatic organ colonisation","volume":"25","author":"Gassmann","year":"2008","journal-title":"Clin. Exp. Metastasis"},{"issue":"3","key":"10.1016\/j.bcp.2023.115415_b0185","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1590\/S1807-59322011000300018","article-title":"Angiogenesis in the progression of cutaneous squamous cell carcinoma: an immunohistochemical study of endothelial markers","volume":"66","author":"Florence","year":"2011","journal-title":"Clinics"},{"issue":"3","key":"10.1016\/j.bcp.2023.115415_b0190","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0092-8674(00)80108-7","article-title":"Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis","volume":"86","author":"Hanahan","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2023.115415_b0195","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3293","article-title":"Cutaneous Squamous Cell Carcinoma Tumour Size is Associated with Sentinel Lymph Node Metastasis in a Cohort of 69 Patients","author":"Chabrillac","year":"2019","journal-title":"Acta Derm. Venereol."},{"issue":"8","key":"10.1016\/j.bcp.2023.115415_b0200","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1056\/NEJMoa1112302","article-title":"Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib","volume":"366","author":"Sosman","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.bcp.2023.115415_b0205","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1080\/14656566.2017.1316372","article-title":"Non-melanoma skin cancer: new and future synthetic drug treatments","volume":"18","author":"Amaral","year":"2017","journal-title":"Expert Opin. Pharmacother."},{"issue":"11","key":"10.1016\/j.bcp.2023.115415_b0210","doi-asserted-by":"crossref","first-page":"5186","DOI":"10.1158\/0008-5472.CAN-06-4506","article-title":"T-lymphokine-activated killer cell-originated protein kinase functions as a positive regulator of c-Jun-NH2-kinase 1 signaling and H-Ras-induced cell transformation","volume":"67","author":"Oh","year":"2007","journal-title":"Cancer Res."},{"issue":"15","key":"10.1016\/j.bcp.2023.115415_b0215","doi-asserted-by":"crossref","first-page":"6601","DOI":"10.1158\/0008-5472.CAN-04-4184","article-title":"Loss of tumor suppressor p53 decreases PTEN expression and enhances signaling pathways leading to activation of activator protein 1 and nuclear factor kappaB induced by UV radiation","volume":"65","author":"Wang","year":"2005","journal-title":"Cancer Res."},{"issue":"3\u20134","key":"10.1016\/j.bcp.2023.115415_b0220","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10555-011-9306-z","article-title":"Cyclooxygenase-dependent signaling is causally linked to non-melanoma skin carcinogenesis: pharmacological, genetic, and clinical evidence","volume":"30","author":"Muller-Decker","year":"2011","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bcp.2023.115415_b0225","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.semcancer.2022.11.009","article-title":"Targeting oncogenic transcription factors in skin malignancies: An update on cancer stemness and therapeutic outcomes","volume":"87","author":"Steinhoff","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"5","key":"10.1016\/j.bcp.2023.115415_b0230","first-page":"E275","article-title":"Immunohistochemical analysis of the patterns of p53 and PCNA expression in odontogenic cystic lesions, Med. Oral Patol. Oral","volume":"13","author":"de Oliveira","year":"2008","journal-title":"Cir. Bucal."},{"issue":"6","key":"10.1016\/j.bcp.2023.115415_b0235","doi-asserted-by":"crossref","first-page":"12222","DOI":"10.3390\/ijms140612222","article-title":"UV radiation and the skin","volume":"14","author":"D'Orazio","year":"2013","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.bcp.2023.115415_b0240","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/mc.20222","article-title":"Molecular and cellular targets","volume":"45","author":"Bode","year":"2006","journal-title":"Mol. Carcinog."},{"issue":"8","key":"10.1016\/j.bcp.2023.115415_b0245","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.2174\/1871520619666190301123131","article-title":"Gossypetin Inhibits Solar-UV Induced Cutaneous Basal Cell Carcinoma Through Direct Inhibiting PBK\/TOPK Protein Kinase","volume":"19","author":"Wang","year":"2019","journal-title":"Anticancer Agents Med Chem."},{"issue":"16","key":"10.1016\/j.bcp.2023.115415_b0250","doi-asserted-by":"crossref","first-page":"27093","DOI":"10.18632\/oncotarget.15636","article-title":"Paeonol suppresses solar ultraviolet-induced skin inflammation by targeting T-LAK cell-originated protein kinase","volume":"8","author":"Xue","year":"2017","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.bcp.2023.115415_b0255","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1158\/1535-7163.MCT-17-0212","article-title":"ADA-07 Suppresses Solar Ultraviolet-Induced Skin Carcinogenesis by Directly Inhibiting TOPK","volume":"16","author":"Gao","year":"2017","journal-title":"Mol. Cancer Ther."},{"issue":"Suppl 8","key":"10.1016\/j.bcp.2023.115415_b0260","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/jdv.16024","article-title":"Medical treatment of advanced cutaneous squamous-cell carcinoma","volume":"33","author":"Gellrich","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"3","key":"10.1016\/j.bcp.2023.115415_b0265","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jaad.2017.10.007","article-title":"Guidelines of care for the management of cutaneous squamous cell carcinoma","volume":"78","author":"Work","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.bcp.2023.115415_b0270","doi-asserted-by":"crossref","unstructured":"J. Ramos, J. Villa, A. Ruiz, R. Armstrong, J. Matta, UV dose determines key characteristics of nonmelanoma skin cancer, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 13(12) (2004) 2006-11.","DOI":"10.1158\/1055-9965.2006.13.12"},{"issue":"6","key":"10.1016\/j.bcp.2023.115415_b0275","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1562\/0031-8655(2000)072<0788:KOULIC>2.0.CO;2","article-title":"Kinetics of UV light-induced cyclobutane pyrimidine dimers in human skin in vivo: an immunohistochemical analysis of both epidermis and dermis","volume":"72","author":"Katiyar","year":"2000","journal-title":"Photochem. Photobiol."},{"issue":"3","key":"10.1016\/j.bcp.2023.115415_b0280","first-page":"977","article-title":"Early p53-positive foci as indicators of tumor risk in ultraviolet-exposed hairless mice: kinetics of induction, effects of DNA repair deficiency, and p53 heterozygosity","volume":"61","author":"Rebel","year":"2001","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.bcp.2023.115415_b0285","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1046\/j.0022-202x.2001.01580.x","article-title":"Protection against pyrimidine dimers, p53, and 8-hydroxy-2'-deoxyguanosine expression in ultraviolet-irradiated human skin by sunscreens: difference between UVB + UVA and UVB alone sunscreens","volume":"117","author":"Liardet","year":"2001","journal-title":"J. Invest. Dermatol."},{"issue":"2","key":"10.1016\/j.bcp.2023.115415_b0290","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jaad.2017.08.059","article-title":"Cutaneous squamous cell carcinoma: Incidence, risk factors, diagnosis, and staging","volume":"78","author":"Que","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"issue":"10","key":"10.1016\/j.bcp.2023.115415_b0295","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.prp.2015.07.006","article-title":"p53 immunoexpression in stepwise progression of cutaneous squamous cell carcinoma and correlation with angiogenesis and cellular proliferation","volume":"211","author":"Florence","year":"2015","journal-title":"Pathol. Res. Pract."},{"issue":"46","key":"10.1016\/j.bcp.2023.115415_b0300","doi-asserted-by":"crossref","first-page":"10773","DOI":"10.1523\/JNEUROSCI.3207-05.2005","article-title":"PBK\/TOPK, a proliferating neural progenitor-specific mitogen-activated protein kinase kinase","volume":"25","author":"Dougherty","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2023.115415_b0305","first-page":"3771711","article-title":"TOPK Affects Autophagy of Skin Squamous Cell Carcinoma by Regulating NF-KB Pathway through HDAC1","volume":"2022","author":"Li","year":"2022","journal-title":"Dis. Markers"},{"key":"10.1016\/j.bcp.2023.115415_b0310","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2147\/DDDT.S326332","article-title":"Promising Natural Products in New Drug Design, Development, and Therapy for Skin Disorders: An Overview of Scientific Evidence and Understanding Their Mechanism of Action, Drug Des","volume":"16","author":"Mohd Zaid","year":"2022","journal-title":"Devel. Ther."},{"key":"10.1016\/j.bcp.2023.115415_b0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcancer.2019.12.008","article-title":"Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: A novel therapeutic strategy","volume":"80","author":"Tewari","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bcp.2023.115415_b0320","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.semcancer.2020.05.009","article-title":"Modulation of the tumor microenvironment by natural agents: implications for cancer prevention and therapy","volume":"80","author":"Zubair","year":"2022","journal-title":"Semin. Cancer Biol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295223000060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295223000060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:39:51Z","timestamp":1757770791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295223000060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":64,"alternative-id":["S0006295223000060"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115415","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Orobol, 3\u2032-hydroxy-genistein, suppresses the development and regrowth of cutaneous SCC","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115415","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115415"}}